Skip to content

Measuring the glycemic index (GI) of fruit extract

Measuring the glycemic index (GI) of fruit extract - Measuring the glycemic index (GI) of fruit extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046402
Enrollment
10
Registered
2021-12-17
Start date
2022-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: single dose Test food: Fruit Extract 71.4 g Reference food1: Glucose 25 g Reference food2: Glucose 15.5 g + Fructose 9.5 g Administration: &lt
After taking blood samples before intake, dissolve the test food in 150 mL of water and drink it. &lt
After taking blood samples before intake, dissolve the reference food in 150 mL of water and drink it. * The intervention sequence order is 1) reference food1, 2) reference food1, 3) test food and 4)

Sponsors

Oneness Support Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy Japanese adult subjects 2.Subjects who are 30 kg/m^2 or less in BMI 3.Subjects who have written consent for participation in the study

Exclusion criteria

Exclusion criteria: 1.Subjects with a history of diabetes, cirrhosis, chronic hepatitis, renal failure, heart failure, cerebral infarction, cerebral hemorrhage, myocardial infraction, angina pectoris, a history of cancer, or a history of surgery of the digestive system (esophagus, stomach, duodenum, small intestine, large intestine, rectal, gallbladder, pancreas) 2.Subjects who currently have a disease under treatment 3.Subjects with fruit allergies 4.Subjects who have abnormal glucose tolerance 5.Subjects who take medications known to affect glucose tolerance 6.Subjects who a pregnant, breast-feeding, and planning to become pregnant or breast-feeding 7.Subjects who are participating in other clinical trials or scheduled to participate in the trial or are less than three months after the end of the trial 8.Subjects judged inappropriate by the doctor responsible for the examination

Design outcomes

Primary

MeasureTime frame
GI

Countries

Japan

Contacts

Public ContactYukino Koshinaka

Miki Corporation Institute for Health science

koshinaka@mikiprune.co.jp0798-43-1870

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026